Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer’s disease in Brazil

Objective: To perform a cost-effectiveness analysis of donepezil and rivastigmine therapy for mild and moderate Alzheimer’s disease (AD) from the perspective of the Brazilian Unified Health System. Method: A hypothetical cohort of 1,000 individuals of both sexes, aged >65 years, and diagnosed wi...

Full description

Bibliographic Details
Main Authors: Luciana R. da Silva, Cid M.M. Vianna, Gabriela B.G. Mosegui, Antônio A.F. Peregrino, Valeska Marinho, Jerson Laks
Format: Article
Language:English
Published: Associação Brasileira de Psiquiatria (ABP) 2018-11-01
Series:Brazilian Journal of Psychiatry
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462018005009101&lng=en&tlng=en

Similar Items